Webby, R.J. The practical longevity of stockpiled A(H5N1) influenza vaccine. Nat Med (2024)
Stockpiled A(H5N1) influenza vaccines made using viruses from the mid-2000s stimulate antibodies that cross-react with current strains, despite being separated by 20 years of viral evolution — supporting investment in vaccine stockpiling for pandemic preparedness.
See Also:
Latest articles in those days:
- T cell help is a limiting factor for rare anti-influenza memory B cells to reenter germinal centers and generate potent broadly neutralizing antibodies 20 hours ago
- Wild birds drive the introduction, maintenance, and spread of H5N1 clade 2.3.4.4b high pathogenicity avian influenza viruses in Spain, 2021-2022 20 hours ago
- [preprint]FluNexus: a versatile web platform for antigenic prediction and visualization of influenza A viruses 21 hours ago
- Salpingitis and multiorgan lesions caused by highly pathogenic avian influenza A(H5N1) virus in a cat associated with consumption of recalled raw milk in California 21 hours ago
- Detection of highly pathogenic avian influenza A(H5N1) virus 2.3.4.4b in alpacas 21 hours ago
[Go Top] [Close Window]
